Skip to Main content Skip to Navigation
New interface
Conference papers

Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice

Hélène Castel 1 T Al Sagheer 1 Martine Dubois 1 Cynthia Campart 1 Laurence Desrues 1 Marie Lange 2 Pierrick Gandolfo 1 Florence Joly 2 
1 DC2N - Différenciation et communication neuronale et neuroendocrine
2 UNICANCER/CRLC - Centre Régional de Lutte contre le Cancer François Baclesse [Caen]
Document type :
Conference papers
Complete list of metadata
https://hal-normandie-univ.archives-ouvertes.fr/hal-02294639
Contributor : Hélène CASTEL Connect in order to contact the contributor
Submitted on : Monday, September 23, 2019 - 3:57:08 PM
Last modification on : Wednesday, March 2, 2022 - 3:48:02 PM

Identifiers

  • HAL Id : hal-02294639, version 1

Collections

COMUE-NORMANDIE | UNIROUEN | DC2N

Citation

Hélène Castel, T Al Sagheer, Martine Dubois, Cynthia Campart, Laurence Desrues, et al.. Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice. 2019 ASCO annual meeting, May 2019, Chicago, United States. ⟨hal-02294639⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

24